The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Cavaletti, G; Cornblath, D R; Merkies, I S J; Postma, T J; Rossi, E; Frigeni, B; Alberti, P; Bruna, J; Velasco, R; Argyriou, A A; Kalofonos, H P; Psimaras, D; Ricard, D; Pace, A; Galiè, E; Briani, C; Dalla Torre, C; Faber, C G; Lalisang, R I; Boogerd, W; Brandsma, D; Koeppen, S; Hense, J; Storey, D; Kerrigan, S; Schenone, A; Fabbri, S; Valsecchi, M G; Mazzeo, A; Pace, A; Pessino, A; Schenone, A; Toscano, A; Argyriou, A A; Brouwer, B; Frigeni, B; Piras, B; Briani, C; Dalla Torre, C; Dominguez Gonzalez, C; Faber, C G; Tomasello, C; Binda, D; Brandsma, D; Cortinovis, D; Psimaras, D; Ricard, D; Storey, D; Cornblath, D R; Galiè, E

Cavaletti, G; Cornblath, D R; Merkies, I S J; Postma, T J; Rossi, E; Frigeni, B; Alberti, P; Bruna, J; Velasco, R; Argyriou, A A; Kalofonos, H P; Psimaras, D; Ricard, D; Pace, A; Galiè, E; Briani, C; Dalla Torre, C; Faber, C G; Lalisang, R I; Boogerd, W; Brandsma, D; Koeppen, S; Hense, J; Storey, D; Kerrigan, S; Schenone, A; Fabbri, S; Valsecchi, M G; Mazzeo, A; Pace, A; Pessino, A; Schenone, A; Toscano, A; Argyriou, A A; Brouwer, B; Frigeni, B; Piras, B; Briani, C; Dalla Torre, C; Dominguez Gonzalez, C; Faber, C G; Tomasello, C; Binda, D; Brandsma, D; Cortinovis, D; Psimaras, D; Ricard, D; Storey, D; Cornblath, D R; Galiè, E.

Afiliación

Cavaletti G; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy. Electronic address: guido.cavaletti@unimib.it.
Cornblath DR; Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Merkies ISJ; Department of Neurology, Spaarne Hospital, Hoofddorp/Maastricht, University Medical Center, Maastricht.
Postma TJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Rossi E; Center of Biostatistics for Clinical Epidemiology, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.
Frigeni B; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy.
Alberti P; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy.
Bruna J; Unit of Neuro-Oncology, Department of Neurology, University Hospital of Bellvitge, L'Hospitalet, Spain.
Velasco R; Unit of Neuro-Oncology, Department of Neurology, University Hospital of Bellvitge, L'Hospitalet, Spain.
Argyriou AA; Division of Clinical Oncology, Department of Medicine, University Hospital of Patras, Patras, Greece.
Kalofonos HP; Division of Clinical Oncology, Department of Medicine, University Hospital of Patras, Patras, Greece.
Psimaras D; Service de Neurologie Mazarin, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris.
Ricard D; Service de Neurologie, Hôpital du Val-de-Grâce, Service de Santé des Armées, Paris, France.
Pace A; Neurology Unit, National Cancer Institute Regina Elena, Rome.
Galiè E; Neurology Unit, National Cancer Institute Regina Elena, Rome.
Briani C; Department of Neurosciences, University of Padova, Padova, Italy.
Dalla Torre C; Department of Neurosciences, University of Padova, Padova, Italy.
Faber CG; Department of Neurology, Spaarne Hospital, Hoofddorp/Maastricht, University Medical Center, Maastricht.
Lalisang RI; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht.
Boogerd W; Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Brandsma D; Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Koeppen S; Department of Neurology and West German Cancer Center, University of Essen, Essen, Germany.
Hense J; Department of Neurology and West German Cancer Center, University of Essen, Essen, Germany.
Storey D; Edinburgh Centre for Neuro-Oncology and Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
Kerrigan S; Edinburgh Centre for Neuro-Oncology and Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
Schenone A; Department of Neurosciences, Ophthalmology and Genetic, Center of Excellence for Biomedical Research, University of Genova, Genova, Italy.
Fabbri S; Department of Neurosciences, Ophthalmology and Genetic, Center of Excellence for Biomedical Research, University of Genova, Genova, Italy.
Valsecchi MG; Center of Biostatistics for Clinical Epidemiology, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.

Ann Oncol ; 24(2): 454-462, 2013 Feb.

Article en En | MEDLINE | ID: mdl-22910842

Asunto(s)

Antineoplásicos/efectos adversos; Antineoplásicos/uso terapéutico; Neoplasias/tratamiento farmacológico; Enfermedades del Sistema Nervioso Periférico/inducido químicamente; Estudios Transversales; Estado de Salud; Humanos; Evaluación de Resultado en la Atención de Salud; Calidad de Vida; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades del Sistema Nervioso Periférico / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google